Combined SFK/MEK inhibition prevents metastatic outgrowth of dormant tumor cells
Published 2013 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Combined SFK/MEK inhibition prevents metastatic outgrowth of dormant tumor cells
Authors
Keywords
-
Journal
JOURNAL OF CLINICAL INVESTIGATION
Volume 124, Issue 1, Pages 156-168
Publisher
American Society for Clinical Investigation
Online
2013-12-08
DOI
10.1172/jci70259
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Phase II Trial of MEK Inhibitor Selumetinib (AZD6244, ARRY-142886) in Patients with BRAFV600E/K-Mutated Melanoma
- (2013) F. Catalanotti et al. CLINICAL CANCER RESEARCH
- c-Src expression is predictive of poor prognosis in breast cancer patients with bone metastasis, but not in patients with visceral metastasis
- (2012) LINGYUN ZHANG et al. APMIS
- Cancer statistics, 2012
- (2012) Rebecca Siegel et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Src kinases catalytic activity regulates proliferation, migration and invasiveness of MDA-MB-231 breast cancer cells
- (2012) María Pilar Sánchez-Bailón et al. CELLULAR SIGNALLING
- Dormant but migratory tumour cells in desmoplastic stroma of invasive ductal carcinomas
- (2012) Vanisri Raviraj et al. CLINICAL & EXPERIMENTAL METASTASIS
- The extracellular matrix: A dynamic niche in cancer progression
- (2012) Pengfei Lu et al. JOURNAL OF CELL BIOLOGY
- Combination of MEK and SRC inhibition suppresses melanoma cell growth and invasion
- (2012) J Ferguson et al. ONCOGENE
- Subcellular Localization of Total and Activated Src Kinase in African American and Caucasian Breast Cancer
- (2012) Muralidharan Anbalagan et al. PLoS One
- Phase II Trial of Saracatinib (AZD0530), an Oral SRC-inhibitor for the Treatment of Patients with Hormone Receptor-negative Metastatic Breast Cancer
- (2011) Ayca Gucalp et al. Clinical Breast Cancer
- A phase II trial of the Src kinase inhibitor saracatinib (AZD0530) in patients with metastatic or locally advanced gastric or gastro esophageal junction (GEJ) adenocarcinoma: a trial of the PMH phase II consortium
- (2011) Helen J. Mackay et al. INVESTIGATIONAL NEW DRUGS
- The Role of p27 Kip1 in Dasatinib-Enhanced Paclitaxel Cytotoxicity in Human Ovarian Cancer Cells
- (2011) Xiao-Feng Le et al. JNCI-Journal of the National Cancer Institute
- Down-regulation of epithelial cadherin is required to initiate metastatic outgrowth of breast cancer
- (2011) Michael K. Wendt et al. MOLECULAR BIOLOGY OF THE CELL
- The roles of TGF-β signaling in carcinogenesis and breast cancer metastasis
- (2011) Takeshi Imamura et al. Breast Cancer
- Elevated Src kinase activity attenuates tamoxifen response in vitro and is associated with poor prognosis clinically.
- (2010) Liam Morgan et al. CANCER BIOLOGY & THERAPY
- Metastatic Growth from Dormant Cells Induced by a Col-I-Enriched Fibrotic Environment
- (2010) D. Barkan et al. CANCER RESEARCH
- Phase I Safety, Pharmacokinetics, and Inhibition of Src Activity Study of Saracatinib in Patients with Solid Tumors
- (2010) J. Baselga et al. CLINICAL CANCER RESEARCH
- Extracellular matrix: A gatekeeper in the transition from dormancy to metastatic growth
- (2010) Dalit Barkan et al. EUROPEAN JOURNAL OF CANCER
- Modeling metastasis biology and therapy in real time in the mouse lung
- (2010) Arnulfo Mendoza et al. JOURNAL OF CLINICAL INVESTIGATION
- Is Expression or Activation of Src Kinase Associated with Cancer-Specific Survival in ER-, PR- and HER2-Negative Breast Cancer Patients?
- (2009) Beatrix Elsberger et al. AMERICAN JOURNAL OF PATHOLOGY
- Latent Bone Metastasis in Breast Cancer Tied to Src-Dependent Survival Signals
- (2009) Xiang H.-F. Zhang et al. CANCER CELL
- Genetic and cell biological analysis of integrin outside-in signaling
- (2009) K. R. Legate et al. GENES & DEVELOPMENT
- Preclinical anticancer activity of the potent, oral Src inhibitor AZD0530
- (2009) Tim P. Green et al. Molecular Oncology
- Association between mitochondrial DNA 4,977 bp deletion and NAD(P)H:quinone oxidoreductase 1 C609T polymorphism in human breast tissues
- (2009) Lee ONCOLOGY REPORTS
- Inhibition of Metastatic Outgrowth from Single Dormant Tumor Cells by Targeting the Cytoskeleton
- (2008) D. Barkan et al. CANCER RESEARCH
- Quantification of Focal Adhesion Kinase Activation Loop Phosphorylation as a Biomarker of Src Activity
- (2008) E. Ciccimaro et al. MOLECULAR PHARMACOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now